Identification and validation of an immune-related prognostic signature and key gene in papillary thyroid carcinoma

被引:20
作者
Qin, Rujia [1 ]
Li, Chunyan [1 ]
Wang, Xuemin [1 ]
Zhong, Zhaoming [1 ,2 ]
Sun, Chuanzheng [1 ]
机构
[1] Kunming Med Univ, Dept Head & Neck Surg Sect 2, Affiliated Hosp 3, Yunnan Canc Hosp, 519 Kunzhou Rd, Kunming 650118, Yunnan, Peoples R China
[2] Kunming Med Univ, Dept Med Oncol, Affiliated Hosp 1, 295 Xichang Rd, Kunming 650032, Yunnan, Peoples R China
基金
中国国家自然科学基金;
关键词
Papillary thyroid carcinoma; Immune-related genes; Prognosis; PPI; Tumor infiltrating immune cells; R PACKAGE; EXPRESSION; CANCER; IMMUNOTHERAPY; SURVIVAL; ASSOCIATION; METASTASIS; DIAGNOSIS; THERAPY;
D O I
10.1186/s12935-021-02066-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Papillary thyroid carcinoma (PTC) is the most common pathological type of thyroid cancer. The effect of traditional anti-tumor therapy is not ideal for the patients with recurrence, metastasis and radioiodine resistance. The abnormal expression of immune-related genes (IRGs) has critical roles in the etiology of PTC. However, the effect of IRGs on PTC prognosis remains unclear. Methods Based on The Cancer Genome Atlas (TCGA) and ImmPort databases, we integrated IRG expression profiles and progression-free intervals (PFIs) of PTC patients. First, we identified the differentially expressed IRGs and transcription factors (TFs) in PTC. Subsequently, an IRG model that can predict the PFI was constructed by using univariate Cox regression, least absolute shrinkage and selection operator (LASSO) regression and multivariate Cox regression analyses of the differentially expressed IRGs in the TCGA. Additionally, a protein-protein interaction (PPI) network showed the interactions between the differentially expressed genes (DEGs), and the top 30 genes with the highest degree were extracted from the network. Then, the key IRG was identified by the intersection analysis of the PPI network and univariate Cox regression, which was verified the differential expression of by western blotting and immunohistochemistry (IHC). ssGSEA was performed to understand the correlation between the key IRG expression level and immune activity. Results A total of 355 differentially expressed IRGs and 43 differentially expressed TFs were identified in PTC patients. Then, eight IRGs were finally utilized to construct an IRG model. The respective areas under the curve (AUCs) of the IRG model reached 0.948, 0.820, and 0.831 at 1, 3 and 5 years in the training set. In addition, lactotransferrin (LTF) was determined as the key IRG related to prognosis. The expression level of LTF in tumor tissues was significantly lower than that in normal tissues. And the results of ssGSEA showed the expression level of LTF is closely related to immune activity. Conclusions These findings show that the prognostic model and key IRG may become promising molecular markers for the prognosis of PTC patients.
引用
收藏
页数:15
相关论文
共 49 条
[11]   Lactoferrin-containing immunocomplex mediates antitumor effects by resetting tumor-associated macrophages to M1 phenotype [J].
Dong, Hongliang ;
Yang, Yueyao ;
Gao, Chenhui ;
Sun, Hehe ;
Wang, Hongmin ;
Hong, Chao ;
Wang, Jun ;
Gong, Fangyuan ;
Gao, Xiaoming .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
[12]   Natural killer group 2D receptor and its ligands in cancer immune escape [J].
Duan, Shixin ;
Guo, Weihua ;
Xu, Zuxing ;
He, Yunbo ;
Liang, Chuting ;
Mo, Yongzhen ;
Wang, Yian ;
Xiong, Fang ;
Guo, Can ;
Li, Yong ;
Li, Xiaoling ;
Li, Guiyuan ;
Zeng, Zhaoyang ;
Xiong, Wei ;
Wang, Fuyan .
MOLECULAR CANCER, 2019, 18 (1)
[13]   Biologic and Clinical Perspectives on Thyroid Cancer [J].
Fagin, James A. ;
Wells, Samuel A., Jr. .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (11) :1054-1067
[14]   The Tumor Suppressor TGFBR3 Blocks Lymph Node Metastasis in Head and Neck Cancer [J].
Fang, Wei-Yu ;
Kuo, Yi-Zih ;
Chang, Jang-Yang ;
Hsiao, Jenn-Ren ;
Kao, Hung-Ying ;
Tsai, Sen-Tien ;
Wu, Li-Wha .
CANCERS, 2020, 12 (06)
[15]   Immunotherapy for advanced thyroid cancers - rationale, current advances and future strategies [J].
French, Jena D. .
NATURE REVIEWS ENDOCRINOLOGY, 2020, 16 (11) :629-641
[16]  
George Nelson, 2018, Indian J Endocrinol Metab, V22, P339, DOI 10.4103/ijem.IJEM_86_18
[17]   Programmed Death-Ligand 1 (PD-L1) Is a Potential Biomarker of Disease-Free Survival in Papillary Thyroid Carcinoma: a Systematic Review and Meta-Analysis of PD-L1 Immunoexpression in Follicular Epithelial Derived Thyroid Carcinoma [J].
Girolami, Ilaria ;
Pantanowitz, Liron ;
Mete, Ozgur ;
Brunelli, Matteo ;
Marletta, Stefano ;
Colato, Chiara ;
Trimboli, Pierpaolo ;
Crescenzi, Anna ;
Bongiovanni, Massimo ;
Barbareschi, Mattia ;
Eccher, Albino .
ENDOCRINE PATHOLOGY, 2020, 31 (03) :291-300
[18]   Soluble Ligands for the NKG2D Receptor Are Released during Endometriosis and Correlate with Disease Severity [J].
Gonzalez-Foruria, Inaki ;
Santulli, Pietro ;
Chouzenoux, Sandrine ;
Carmona, Francisco ;
Batteux, Frederic ;
Chapron, Charles .
PLOS ONE, 2015, 10 (03)
[19]   Combinations of BRAF inhibitor and anti-PD-1/PD-L1 antibody improve survival and tumour immunity in an immunocompetent model of orthotopic murine anaplastic thyroid cancer [J].
Gunda, Viswanath ;
Gigliotti, Benjamin ;
Ndishabandi, Dorothy ;
Ashry, Tameem ;
McCarthy, Michael ;
Zhou, Zhiheng ;
Amin, Salma ;
Freeman, Gordon J. ;
Alessandrini, Alessandro ;
Parangi, Sareh .
BRITISH JOURNAL OF CANCER, 2018, 119 (10) :1223-1232
[20]   Increasing diagnosis of subclinical thyroid cancers leads to spurious improvements in survival rates [J].
Ho, Allen S. ;
Davies, Louise ;
Nixon, Iain J. ;
Palmer, Frank L. ;
Wang, Laura Y. ;
Patel, Snehal G. ;
Ganly, Ian ;
Wong, Richard J. ;
Tuttle, R. Michael ;
Morris, Luc G. T. .
CANCER, 2015, 121 (11) :1793-1799